PAD Regimen - CISMeF

Preferred Label : PAD Regimen;

NCIt synonyms : PS-341/Adriamycin/Dexamethasone Regimen; PAD; Velcade/Adriamycin/Dexamethasone Regimen; Bortezomib/Doxorubicin/Dexamethasone Regimen; Bortezomib/ Dexamethasone/Doxorubicin; Bortezomib/Dexamethasone/Doxorubicin;

NCIt definition : A regimen containing bortezomib, doxorubicin and dexamethasone regimen used in the treatment of plasma cell myeloma.;

NCI Metathesaurus CUI : CL472264;

Codes from synonyms : 26268;

Details

Origin ID

C114387;

UMLS CUI

C3814046;

False automatic mappings
- Chronic arterial occlusive disease [Bloc CIM-11]
- Pad (morphologic abnormality) [SNOMED CT concept]
- Pad (unit of presentation) [SNOMED CT concept]
- Pad - unit of product usage (qualifier value) [SNOMED CT concept]
- Padding (qualifier value) [SNOMED CT concept]
- Patent arterial duct [ORDO Disease]
- Peptidylarginine deiminase, type iv [OMIM gene]
- pad [UBERON concept]
- peripheral arterial disease [MedlinePlus Topic]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bortezomib [NCIt concept]
- Dexamethasone [NCIt concept]
- Doxorubicin [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients